Optomed Oyj (HEL:OPTOMED)
1.488
+0.066 (4.64%)
Jun 8, 2026, 12:26 PM EET
Optomed Oyj Earnings Call Transcripts
Fiscal Year 2024
-
Q4 delivered robust growth, with group revenue up 39.3% and device revenue surging nearly 150% year-over-year, driven by a major U.S. order. 2025 is expected to see strong growth from AI-powered solutions in the U.S., while the software segment and China remain more modest.